CD44 and cancer: The PI3K/Akt, Wnt, STAT3, NF-κB and Sonic signaling pathways undergo down-regulation by natural products to reduce expression level of CSC markers including CD44, CD133, Notch, Oct4 and Nanog, impairing cancer stemness and progression.